Author Nat Lenzo

Professor Nat Lenzo is a Nuclear Medicine and Internal Medicine Physician and the Medical Director of Theranostics at GenesisCare. From 2001-2006, Nat was the inaugural head of the Western Australia PET/cyclotron service based at Sir Charles Gardiner Hospital. In 2015, Nat founded Theranostics Australia which became part of GenesisCare in 2017 to complement GenesisCare’s radiation oncology services to cancer patients in Australia and internationally. The GenesisCare Theranostics team is committed to developing and using targeted molecular diagnostic imaging and therapeutic agents for the diagnosis and treatment of cancers, with a focus on cancers which are difficult to treat or are becoming resistant to conventional therapies. With a strong track record in developing clinical and research services in the public and private sectors, Nat’s research interests are in new molecular imaging and targeted therapeutic agents in neurosciences and oncology. He is the co-investigator on a number of grants, a principal investigator in several multicentre clinical trials, and a co-author on over 80 peer reviewed publications, predominantly in the areas of molecular imaging and therapy in neuroscience and oncology.